Zobrazeno 1 - 10 of 20 pro vyhledávání: '"Pete Conway"'
1
Akademický článek
The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC).
Autor: Ellen R Berni, Bethan I Jones, Thomas R Berni, James Whitehouse, Mark Hudson, James Orr, Pete Conway, Bharat Amlani, Craig J Currie
Publikováno v: PLoS ONE, Vol 14, Iss 10, p e0223253 (2019)
The purpose of this study was to produce two statistical survival models in those with cirrhosis utilising only routine parameters, including non-liver-related clinical factors that influence survival. The first model identified and utilised factors
Externí odkaz: https://doaj.org/article/08e037486f1e4879acba9463ffc3520e
Zobrazit plný text záznamu
2
The model of mortality with incident cirrhosis (MoMIC) and the model of long-term outlook of mortality in dcirrhosis (LOMiC)
Autor: Mark Hudson, Craig John Currie, Pete Conway, Ellen Berni, James Orr, James Whitehouse, Thomas R Berni, Bethan I Jones, Bharat Amlani
Publikováno v: PLoS ONE, Vol 14, Iss 10, p e0223253 (2019)
PLoS ONE
The purpose of this study was to produce two statistical survival models in those with cirrhosis utilising only routine parameters, including non-liver-related clinical factors that influence survival. The first model identified and utilised factors
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459fced1c11c113796d79ebdb5d2f076
Zobrazit plný text záznamu
3
An evaluation of the association between systemic inflammation – as measured by C-reactive protein – and hospital resource use
Autor: Pete Conway, Christopher David Poole, Craig John Currie
Publikováno v: Current Medical Research and Opinion. 23:2785-2792
To evaluate the association between inflammatory status, as measured by C-reactive protein (CRP), during inpatient admission and subsequent inpatient outcome and associated resource use.Probabilistic record linkage was used to match hospital episode
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d25207dbc8ca165c82ce67d7a36b9373
https://doi.org/10.1185/030079907x233205
Zobrazit plný text záznamu
4
Evaluation of the Cost Effectiveness of Sirolimus versus Tacrolimus for Immunosuppression Following Renal Transplantation in the UK
Autor: Simon Dixon, Pete Conway, Craig John Currie, Keshwar Baboolal, Phil McEwan
Publikováno v: PharmacoEconomics. 24:67-79
Introduction: Immunosuppressive therapy is required to prevent graft rejection. Calcineurin inhibitors such as tacrolimus are paradoxically toxic to the kidney, whereas sirolimus (rapamycin; Rapamune®) is not generally associated with the nephrotoxi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d6c767d2caa93c609b9a99f6075a45
https://doi.org/10.2165/00019053-200624010-00006
Zobrazit plný text záznamu
5
Evaluation of the cost-effectiveness of Sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
Autor: Keshwar Baboolal, Phil McEwan, Craig John Currie, Pete Conway
Publikováno v: Clinical Therapeutics. 27:1834-1846
Objective: The purpose of this study was to evaluate the cost-effectiveness of sirolimus compared with cyclosporin for the postsurgical management of renal transplant recipients, from the perspective of the UK National Health Service and the Personal
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb1a43bf7983646982de506556f7b68
https://doi.org/10.1016/j.clinthera.2005.11.002
Zobrazit plný text záznamu
6
Characterisation and comparison of health-related quality of life for patients with renal failure
Autor: Craig John Currie, Pete Conway, Amanda J. Lee, Christopher L. Morgan
Publikováno v: Current Medical Research and Opinion. 21:1777-1783
Objective: The objective of this study was to assess the health related quality of life (HRQOL) in patients with kidney failure who had received renal transplants compared to those receiving haemodialysis, peritoneal dialysis or were waiting to start
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa8445313d2c1ce60344fbebf9fa874
https://doi.org/10.1185/030079905x65277
Zobrazit plný text záznamu
7
Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK
Autor: Alan Lenox-Smith, Pete Conway, Christopher Knight
Publikováno v: PharmacoEconomics. 22:311-319
Objective: To estimate the cost effectiveness of representatives of three different classes of antidepressants used in major depression in the UK NHS. Design, patients and interventions: A decision-tree model for the treatment of major depression was
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c01cf4e5627db95deb861789cdae46
https://doi.org/10.2165/00019053-200422050-00005
Zobrazit plný text záznamu
9
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine
Autor: R Andrew Moore, Garth Baxter, Hiltrud Liedgens, R. Ikenberg, N. Hertel, M. Obradovic, Pete Conway
Publikováno v: Journal of medical economics. 15(4)
The aim of this analysis was to assess the cost-effectiveness of tapentadol PR (prolonged release) compared with oxycodone CR (controlled release) in severe non-malignant chronic pain patients in whom controlled release morphine was ineffective or no
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db337a1a751ec93306d8dcfc36d7300
https://pubmed.ncbi.nlm.nih.gov/22364286
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje